Charles Ferte

Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 59 publications

Automated extraction of temporalized tumor evolution from oncology EMRs using natural language processing.

Automated extraction of temporalized tumor evolution from oncology EMRs using natural language processing.

Journal: ESMO real world data and digital oncology

Published: April 03, 2026

Proposals to develop innovation and research in cancer and optimize care for patients affected by cancer

Proposals to develop innovation and research in cancer and optimize care for patients affected by cancer

Journal: Bulletin du cancer

Published: May 19, 2025

A phase 1 study of the CD40 agonist MEDI5083 in combination with durvalumab in patients with advanced solid tumors.

A phase 1 study of the CD40 agonist MEDI5083 in combination with durvalumab in patients with advanced solid tumors.

Journal: Immunotherapy

Published: September 12, 2024

The Effect of Nurse Navigators in Digital Remote Monitoring in Cancer Care: Case Study Using Structural Equation Modeling.

The Effect of Nurse Navigators in Digital Remote Monitoring in Cancer Care: Case Study Using Structural Equation Modeling.

Journal: Journal of medical Internet research

Published: September 11, 2024

Implementation of a remote symptom monitoring pathway in oncology care: analysis of real-world experience across 33 cancer centres in France and Belgium.

Implementation of a remote symptom monitoring pathway in oncology care: analysis of real-world experience across 33 cancer centres in France and Belgium.

Journal: The Lancet regional health. Europe

Published: March 29, 2024

Primary Colorectal Tumor Displays Differential Genomic Expression Profiles Associated with Hepatic and Peritoneal Metastases.

Primary Colorectal Tumor Displays Differential Genomic Expression Profiles Associated with Hepatic and Peritoneal Metastases.

Journal: Cancers

Published: July 15, 2023

Comparison of Fast-Progression, Hyperprogressive Disease, and Early Deaths in Advanced Non-Small-Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors or Chemotherapy.

Comparison of Fast-Progression, Hyperprogressive Disease, and Early Deaths in Advanced Non-Small-Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors or Chemotherapy.

Journal: JCO precision oncology

Published: November 01, 2020

Radiomics to predict outcomes and abscopal response of patients with cancer treated with immunotherapy combined with radiotherapy using a validated signature of CD8 cells.

Radiomics to predict outcomes and abscopal response of patients with cancer treated with immunotherapy combined with radiotherapy using a validated signature of CD8 cells.

Journal: Journal for immunotherapy of cancer

Published: September 29, 2020

Safety and clinical activity of intratumoral MEDI9197 alone and in combination with durvalumab and/or palliative radiation therapy in patients with advanced solid tumors.

Safety and clinical activity of intratumoral MEDI9197 alone and in combination with durvalumab and/or palliative radiation therapy in patients with advanced solid tumors.

Journal: Journal for immunotherapy of cancer

Published: August 23, 2020

Evidence of pseudoprogression in patients treated with PD1/PDL1 antibodies across tumor types.

Evidence of pseudoprogression in patients treated with PD1/PDL1 antibodies across tumor types.

Journal: Cancer medicine

Published: September 06, 2019

Correction to: 33rd Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2018).

Correction to: 33rd Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2018).

Journal: Journal for immunotherapy of cancer

Published: February 15, 2019

Safety and clinical activity of the Notch inhibitor, crenigacestat (LY3039478), in an open-label phase I trial expansion cohort of advanced or metastatic adenoid cystic carcinoma.

Safety and clinical activity of the Notch inhibitor, crenigacestat (LY3039478), in an open-label phase I trial expansion cohort of advanced or metastatic adenoid cystic carcinoma.

Journal: Investigational new drugs

Published: November 13, 2018

Showing 1-12 of 59

Last Updated: 09/26/2026